In addition, the tumour from the homozygous p.Gly264Ser carrier did not show a high HRD score or a strong mutational signature 3 that are characteristic of RAD51C-null tumours, indicating that its HR pathway remained largely intact. The gene discussed is RAD51C; the disease is neoplasm.